Matches in Wikidata for { <http://www.wikidata.org/entity/Q49828207> ?p ?o ?g. }
- Q49828207 description "2018 nî lūn-bûn" @default.
- Q49828207 description "2018年の論文" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年学术文章" @default.
- Q49828207 description "2018年學術文章" @default.
- Q49828207 description "2018年學術文章" @default.
- Q49828207 description "2018年學術文章" @default.
- Q49828207 description "2018年學術文章" @default.
- Q49828207 description "2018年學術文章" @default.
- Q49828207 description "2018년 논문" @default.
- Q49828207 description "article científic" @default.
- Q49828207 description "article scientific" @default.
- Q49828207 description "article scientifique" @default.
- Q49828207 description "articol științific" @default.
- Q49828207 description "articolo scientifico" @default.
- Q49828207 description "artigo científico" @default.
- Q49828207 description "artigo científico" @default.
- Q49828207 description "artigo científico" @default.
- Q49828207 description "artikel ilmiah" @default.
- Q49828207 description "artikull shkencor" @default.
- Q49828207 description "artikulong pang-agham" @default.
- Q49828207 description "artykuł naukowy" @default.
- Q49828207 description "artículo científico publicado en 2018" @default.
- Q49828207 description "artículu científicu" @default.
- Q49828207 description "bilimsel makale" @default.
- Q49828207 description "bài báo khoa học" @default.
- Q49828207 description "naučni članak" @default.
- Q49828207 description "scienca artikolo" @default.
- Q49828207 description "scientific article published on 20 February 2018" @default.
- Q49828207 description "scientific article published on 20 February 2018" @default.
- Q49828207 description "scientific article published on 20 February 2018" @default.
- Q49828207 description "teaduslik artikkel" @default.
- Q49828207 description "tieteellinen artikkeli" @default.
- Q49828207 description "tudományos cikk" @default.
- Q49828207 description "vedecký článok" @default.
- Q49828207 description "vetenskaplig artikel" @default.
- Q49828207 description "videnskabelig artikel" @default.
- Q49828207 description "vitenskapelig artikkel" @default.
- Q49828207 description "vitskapeleg artikkel" @default.
- Q49828207 description "vědecký článek" @default.
- Q49828207 description "wetenschappelijk artikel" @default.
- Q49828207 description "wissenschaftlicher Artikel" @default.
- Q49828207 description "επιστημονικό άρθρο" @default.
- Q49828207 description "мақолаи илмӣ" @default.
- Q49828207 description "наукова стаття, опублікована в лютому 2018" @default.
- Q49828207 description "научна статия" @default.
- Q49828207 description "научная статья" @default.
- Q49828207 description "научни чланак" @default.
- Q49828207 description "научни чланак" @default.
- Q49828207 description "מאמר מדעי" @default.
- Q49828207 description "مقالة علمية نشرت في 20 فبراير 2018" @default.
- Q49828207 description "২০ ফেব্রুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q49828207 description "บทความทางวิทยาศาสตร์" @default.
- Q49828207 description "სამეცნიერო სტატია" @default.
- Q49828207 name "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 name "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 type Item @default.
- Q49828207 label "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 label "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 prefLabel "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 prefLabel "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 P1433 Q49828207-C22EE4AB-8B46-4A33-934F-379064BCE56C @default.
- Q49828207 P1476 Q49828207-E048AFE4-B892-4222-958C-EDD37454F5AC @default.
- Q49828207 P2093 Q49828207-0380EC85-7BB7-4A46-B107-4B52025187E3 @default.
- Q49828207 P2093 Q49828207-07D16C57-6225-4CF2-ADB8-D6776EE2214A @default.
- Q49828207 P2093 Q49828207-157F9250-DC71-4F11-9F5B-042704FA57FA @default.
- Q49828207 P2093 Q49828207-364194CA-B25C-48EA-ADE9-9CEFE0BF2881 @default.
- Q49828207 P2093 Q49828207-5725F25E-B8FA-4571-BC5F-D96E4ED6CBE5 @default.
- Q49828207 P2093 Q49828207-5ED15669-12E3-44B3-BC07-7ABB334921BD @default.
- Q49828207 P2093 Q49828207-603788AA-0BDA-48B1-8DB7-4A7D45BA09CF @default.
- Q49828207 P2093 Q49828207-7B4B79DB-FB33-40C0-B07E-A4E0C878946E @default.
- Q49828207 P2093 Q49828207-83E1C8E2-216E-4635-90F2-4B6CAF87B450 @default.
- Q49828207 P2093 Q49828207-93CC5319-13B5-4B61-80DB-C18EAC18B2D5 @default.
- Q49828207 P2093 Q49828207-AF436C2A-A29B-4FEE-AF91-CEF47DA9855C @default.
- Q49828207 P2093 Q49828207-B52BD2C0-3A4E-4286-86C7-34E32402C0C7 @default.
- Q49828207 P2093 Q49828207-BAC28534-BAAA-4241-A000-7EAB237032DF @default.
- Q49828207 P2093 Q49828207-CDD6C5C0-E64A-4A2E-81F9-2FDF208A9AFE @default.
- Q49828207 P2093 Q49828207-E3C9D66A-99D9-4C9C-8C46-E3BD7F25EB52 @default.
- Q49828207 P2093 Q49828207-E65F0C63-3605-469E-BB2E-E9AA22C6C1C6 @default.
- Q49828207 P2093 Q49828207-EC270DB2-B39C-4DAA-B61F-09EFD85DF882 @default.
- Q49828207 P2093 Q49828207-F0F8E501-57F5-45E0-8468-D7EE4202F03F @default.
- Q49828207 P2093 Q49828207-FF31BFA0-DBD1-4DD0-AD2B-7CAD1ADF6E6F @default.
- Q49828207 P31 Q49828207-27B54D72-B5D1-4D23-9BD5-CD944ECFBE10 @default.
- Q49828207 P356 Q49828207-7519A1D1-91FB-4A2A-B17A-DAC03D2E0EDB @default.
- Q49828207 P407 Q49828207-FE1A716B-454C-4E17-9E5B-6750A018800D @default.
- Q49828207 P50 Q49828207-7A70EE0C-3E35-4CE3-9AF3-612ADBAD4BB9 @default.
- Q49828207 P577 Q49828207-EAE974E0-39A2-484D-AAE3-49C59C8CB31D @default.
- Q49828207 P698 Q49828207-F7EE8091-78DC-41A9-87F4-B020DBFC4BCD @default.
- Q49828207 P921 Q49828207-BD67B7A6-64D9-4BF8-91C5-61CFDCF4EC30 @default.
- Q49828207 P356 M17-1094 @default.
- Q49828207 P698 29459949 @default.
- Q49828207 P1433 Q564416 @default.
- Q49828207 P1476 "Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study." @default.
- Q49828207 P2093 "Anna G Turkina" @default.
- Q49828207 P2093 "Beatriz Moiraghi" @default.
- Q49828207 P2093 "Carla Boquimpani" @default.